ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1899

Aortic Stenosis Is Increased in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Compared to Other Forms of Pulmonary Arterial Hypertension

María Martín López1, Otto Martin Olivas Vergara2, Mario Rodríguez3, Carmen D Merino4, Carmen Jiménez5,6, Estibaliz Loza7, Pilar Escribano5,6, Loreto Carmona8 and Patricia E. Carreira2, 1RHEUMATOLOGY, Hospital Universitario 12 de Octubre, Madrid, Spain, 2Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, 3Hospital Universitario 12 de Octubre, Madrid, Spain, 4Fundación Hospital de Alcorcón, Madrid, Spain, 5Cardiology Department, Hospital Universitario 12 de Octubre, Madrid, Spain, 6Multidisciplinary Pulmonary Hypertension Unit. Hospital Universitario 12 de Octubre, Madrid, Spain, 7Research Unit. Sociedad Española de Reumatología, Madrid, Spain, 8Instituto de Salud Musculoesquelética, Madrid, Spain

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cardiovascular disease, risk assessment and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Degenerative aortic stenosis (DAS) is the most common form of valvular heart disease associated with advancing age. DAS pathophysiology has not been clearly elucidated, but biomechanical factors, inflammation and atherosclerosis are believed to have an essential role in its development. In the last years we have detected an increased frequency of DAS in systemic sclerosis (SSc) patients, especially in those with pulmonary arterial hypertension (PAH), not found in other forms of PAH.

Objective: To analyze the prevalence and risk factors for DAS in SSc-PAH, compared to patients with other forms of PAH.

Methods: All patients with systemic sclerosis (SSc) followed in the Rheumatology Department between Jan 1990 and May 2015 were included in a prospective data base containing demographic and clinical data.  Patients with PAH confirmed by right heart cathetherization (RHC) older than 60 y were selected. As a control group, primary or thromboembolic PAH (IPAH/CTEPH) patients older than 60 were selected from the hospital PH registry. Presence of DAS was defined by transthoracic echocardiography, following current guidelines recommendations. Demographic data, cardiovascular risk factors (smoking, systemic arterial hypertension (HPT), dyslipemia, diabetes mellitus, obesity) and time of follow-up from PAH diagnosis were compared between groups. Descriptive statistics, univariate and multivariate logistic regression analysis were performed.

Results: Thirty three SSc-HAP (30w,3m, 71±6 y) and 85 IPAH/CTEPH (50w,35m, 77±6 y) were included. SSc-HAP patients were younger than IPAH/CTEPH (p<.0001), more frequently women (p=.001), less smokers (p=.04), and had more HTP (p<.0001). Time of follow-up from PAH diagnosis was shorter in SSc patients (4±4y vs 6±4y, p=.02). DAS was present in 6/24 SSc-HAP and in 1/75 IPAH/CTEPH (p=.001). Univariate analysis, showed association of DAS with SSc (p=.004) and HTP (p=.003). Multivariate analysis adjusted by age, sex and cardiovascular risk factors showed SSc as the only independent factor associated with DAS (p=.003) in our group.

Conclusion: Prevalence of degenerative aortic stenosis (DAS) is increased in SSc-PAH, compared with other forms of PAH, and this association is independent of age, sex and cardiovascular risk factors. Our results suggest than inflammation present in SSc-PAH and not in other forms of PAH could be a factor involved in the development of DAS in our patients.


Disclosure: M. Martín López, None; O. M. Olivas Vergara, None; M. Rodríguez, None; C. D. Merino, None; C. Jiménez, None; E. Loza, None; P. Escribano, None; L. Carmona, None; P. E. Carreira, None.

To cite this abstract in AMA style:

Martín López M, Olivas Vergara OM, Rodríguez M, Merino CD, Jiménez C, Loza E, Escribano P, Carmona L, Carreira PE. Aortic Stenosis Is Increased in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Compared to Other Forms of Pulmonary Arterial Hypertension [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/aortic-stenosis-is-increased-in-systemic-sclerosis-patients-with-pulmonary-arterial-hypertension-compared-to-other-forms-of-pulmonary-arterial-hypertension/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/aortic-stenosis-is-increased-in-systemic-sclerosis-patients-with-pulmonary-arterial-hypertension-compared-to-other-forms-of-pulmonary-arterial-hypertension/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology